Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-09-30

FDA Approved: TRINTELLIX — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved TRINTELLIX (vortioxetine) as an Original Application for the treatment of major depressive disorder in adults. It represents the approval of a nove…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRINTELLIX (Vortioxetine)

Snippet

ORIG AP for TRINTELLIX (VORTIOXETINE)